On November 12, Illumina fell 5.06% in Regular Trading, trading at $200.955 per share, with turnover of $18.4239 million.
The most recent market context indicates the stock gave back part of the prior session's gain after investors digested management commentary from a November 10 conference call, where executives said 2027 is on track for high-single-digit revenue growth and at least a 25.5% operating margin as a starting point, while not providing formal 2027 guidance.
That backdrop followed Illumina's latest quarterly results released on October 29: adjusted EPS excluding tariff refunds was $1.44, above the $1.36 consensus, revenue was $1.129 billion versus a $1.154 billion estimate, and full-year adjusted EPS guidance was raised to $5.40-$5.45 from $5.30-$5.40. Recent target-price increases from several brokerages were supportive, but weak China revenue and the lack of formal next-year guidance remained part of the debate.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments